6H90 Stock Chart & Stats
€0.56
-€0.02(-1.65%)
At close: 4:00 PM EST
€0.56
-€0.02(-1.65%)
Day’s Range― - ―
52-Week Range€0.34 - €1.02
Previous CloseN/A
Volume0.00
Average Volume (3M)7.32K
Market Cap
€143.45M
Enterprise Value€294.39
Total Cash (Recent Filing)€21.95M
Total Debt (Recent Filing)€86.73M
Price to Earnings (P/E)―
Beta0.78
Next Earnings
Aug 17, 2026EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.17
Shares Outstanding303,547,420
10 Day Avg. Volume15,230
30 Day Avg. Volume7,320
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)1.70
Price to Sales (P/S)2.03
P/FCF Ratio-10.44
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€1.52Price Target Upside172.05% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)-0.05
Revenue Forecast (FY)€85.05M
Bulls Say, Bears Say
Bulls Say
Revenue And Gross Margin ImprovementSustained revenue growth with materially higher gross margins indicates improving product-market fit and unit economics. If maintained, this creates scope for operating leverage as scale rises, making the business more able to absorb fixed costs and move toward profitability over the medium term.
Improved Leverage And Balance Sheet CapacityReduced leverage versus earlier years improves financial flexibility and lowers refinancing risk, supporting capacity to invest in growth or weather cash shortfalls. A stronger capital structure enhances long-term resilience and reduces interest burden as the company scales.
AI Healthcare Business Model With Structural TailwindA software-centric AI offering targets durable structural demand for analytics in healthcare: care-gap identification, early detection, and population management. Recurring software use, clinical outcomes linkage, and secular digitization trends support sustained addressable market growth and recurring revenue potential.
Bears Say
Persistent Negative Cash FlowOngoing negative operating and free cash flows exhaust capital without internal funding, forcing reliance on external financing. Over months, this elevates dilution or refinancing risk, constrains reinvestment, and can limit runway if revenue conversion to cash lags forecasts.
Continued Operating LossesDespite top-line and gross margin gains, persistent negative operating results show the company has yet to convert improved unit economics into sustained profitability. Prolonged losses erode shareholder equity and reduce options for dividending or buybacks when growth normalizes.
Sharply Negative Free Cash Flow GrowthA steep decline in free cash flow growth signals worsening cash conversion dynamics even as revenue rises. This increases dependence on capital markets, risks higher borrowing costs and dilution, and shortens the time window to prove a self-sustaining business model without external support.
HEALWELL AI News
6H90 FAQ
What was HEALWELL AI’s price range in the past 12 months?
HEALWELL AI lowest stock price was €0.34 and its highest was €1.02 in the past 12 months.
What is HEALWELL AI’s market cap?
HEALWELL AI’s market cap is €143.45M.
When is HEALWELL AI’s upcoming earnings report date?
HEALWELL AI’s upcoming earnings report date is Aug 17, 2026 which is in 25 days.
How were HEALWELL AI’s earnings last quarter?
HEALWELL AI released its earnings results on May 07, 2026. The company reported -€0.012 earnings per share for the quarter, missing the consensus estimate of -€0.012 by >-€0.001.
Is HEALWELL AI overvalued?
According to Wall Street analysts HEALWELL AI’s price is currently Undervalued.
Does HEALWELL AI pay dividends?
HEALWELL AI does not currently pay dividends.
What is HEALWELL AI’s EPS estimate?
HEALWELL AI’s EPS estimate is -0.01.
How many shares outstanding does HEALWELL AI have?
HEALWELL AI has 303,547,420 shares outstanding.
What happened to HEALWELL AI’s price movement after its last earnings report?
HEALWELL AI reported an EPS of -€0.012 in its last earnings report, missing expectations of -€0.012. Following the earnings report the stock price went down -5.145%.
Which hedge fund is a major shareholder of HEALWELL AI?
Currently, no hedge funds are holding shares in DE:6H90
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
HEALWELL AI Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
3.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
26.03%
Trailing 12-Months
Company Description
HEALWELL AI
Healwell AI Inc., a Toronto-based healthcare technology firm established in 2012, specializes in leveraging artificial intelligence and data science to advance preventative medical care. The company develops an AI-powered platform designed to assist healthcare providers with crucial decision-making. They maintain a significant strategic partnership with WELL Health Technologies Corp., focusing on accelerating the expansion and innovation of AI-driven healthcare solutions. Prior to its current name, adopted in October 2023, the organization was known as MCI Onehealth Technologies Inc.
6H90 Stock 12 Month Forecast
Average Price Target
€1.52
▲(172.05% Upside)
Technical Analysis
Cardiocomm Solutions
―
Reliq Health Technologies
―
Leveljump Healthcare Corp.
―
Kovo HealthTech Corporation
―
Hydreight Technologies Inc
―